Literature DB >> 11453592

Discordant prevalence of chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction.

A Clad1, J Prillwitz, K C Hintz, R Mendel, U Flecken, J Schulte-Mönting, E E Petersen.   

Abstract

The following study was conducted to determine whether there would be an effect on the prevalence of Chlamydia trachomatis if both partners in a sexual relationship, rather than only one, underwent screening. First-void urine samples were collected from 1,690 asymptomatic women (mean age, 30 years; range, 15-70 years) and their male sex partners (mean age, 33 years; range, 16-71 years). The duration of sexual partnership for these subjects ranged from 2 months to more than 10 years.. At the time of testing, 687 of the women were pregnant. Ligase chain reaction testing revealed that 42 (2.5%) female and 63 (3.7%) male urine samples were positive. Detection rates for Chlamydia trachomatis differed for males and females, a difference that was found to be significant (P<0.0046, McNemar chi-square). Both partners tested positive in 27 (1.6%) couples, whereas at least one partner tested positive in 78 (4.6%) couples. Thus, screening males for Chlamydia trachomatis would have identified 63 (81%) of these 78 couples compared with only 42 (54%) couples had females been screened exclusively. In standard clinical practice, women most often undergo screening. The results of this study underscore the need to screen both males and females for Chlamydia trachomatis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453592     DOI: 10.1007/pl00011271

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  [Diagnosis and treatment of Chlamydia trachomatis infections].

Authors:  T Meyer
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

2.  Asymptomatic men: should they be tested for urethritis?

Authors:  Paddy Horner
Journal:  Sex Transm Infect       Date:  2007-04       Impact factor: 3.519

Review 3.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 4.  [Urogenital chlamydial infections in women and men].

Authors:  A Clad; W Krause
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

5.  Chlamydia trachomatis infections in Greece: first prevalence study using nucleic acid amplification tests.

Authors:  S Levidiotou; G Vrioni; H Papadogeorgaki; K Avdeliodi; H Kada; G Kaparos; E Kouskouni; E Fragouli; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

6.  Genotype-Specific Concordance of Chlamydia trachomatis Genital Infection Within Heterosexual Partnerships.

Authors:  Julia A Schillinger; Barry P Katz; Lauri E Markowitz; Phillip G Braslins; Lydia A Shrier; Guillermo Madico; Barbara Van Der Pol; Donald P Orr; Peter A Rice; Byron E Batteiger
Journal:  Sex Transm Dis       Date:  2016-12       Impact factor: 2.830

7.  Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.

Authors:  Valentine Akande; Cathy Turner; Paddy Horner; Andrew Horne; Allan Pacey
Journal:  Hum Fertil (Camb)       Date:  2010-09       Impact factor: 2.767

Review 8.  [Epidemiology of chlamydial infections].

Authors:  V Bremer; A Hofmann; O Hamouda
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

9.  Urine based screening for asymptomatic/undiagnosed genital chlamydial infection in young people visiting the accident and emergency department is feasible, acceptable, and can be epidemiologically helpful.

Authors:  T Aldeen; A Haghdoost; P Hay
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

10.  Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany.

Authors:  N Fieser; U Simnacher; Y Tausch; S Werner-Belak; S Ladenburger-Strauss; H von Baum; U Reischl; A Essig
Journal:  Infection       Date:  2012-08-02       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.